Ruomu Li

Ruomu focuses her practice on complex mergers & acquisitions, private equity transactions and venture capital investments. She has nearly 20 years of experience in a broad range of transactions in the life sciences and technology industries, including buy-side and sell-side public and private mergers, going private transactions, de-SPAC transactions, stock and asset acquisitions, divestitures, spinoffs, joint ventures and minority investments.

Ruomu started her legal career in the Silicon Valley and has practiced in the Silicon Valley for close to a decade.

Ruomu’s recent representative matters include:

M&A

• ProfoundBio in its $1.8 billion acquisition by Genmab.
• Tencent in the $2.7 billion sale of its portfolio company Mobike, a bike sharing platform, to Meituan.
• Luxtera a photonic chip maker, in its $660 million sale to Cisco.
• eHi Car Services (representation of the special committee) in its $930 million going private transaction.
• China Electronics Corporation, as a consortium member, in its $693 million taking private transaction of Montage Technology, a semiconductor company.
• TOYO Co., Ltd. in its business combination with special purpose acquisition company Blue World Acquisition Corporation (Nasdaq: BWAQ) and its debut on the Nasdaq.
• Silver Crest Acquisition Corporation (Nasdaq: SLCR), a publicly traded special purpose acquisition company, in connection with its $1.4 billion business combination with TH International Limited, a master franchisee and operator of Tim Hortons coffee shops in China.
• A top institutional investor in Grab’s $40 billion de-SPAC merger with special purpose acquisition company Altimeter Growth Corp.
• A top hedge fund in its merger arbitrage strategy in connection with the $8.7 billion going private transaction of 58.com.
• Ascendent Capital Partners, as a consortium member, in connection with the $230.6 million privatization of Tarena International (Nasdaq: TEDU), a top professional education and K-12 education services provider in China.
• Ascendent Capital Partners in its disposal of Etern Group – which indirectly holds 98% of the equity interest in a general hospital in Suzhou, China – to Hygeia Healthcare Holdings, a Hong Kong listed healthcare company, for a total consideration of RMB1,734,600,000 (approximately $267 million).
• Ocean Imagination, as a consortium member, in its $671 million taking private transaction of eLong, a Chinese online travel services company.
• KongZhong Corporation, a Chinese online game developer and operator, in its $299 million going private transaction.
• Taomee Holdings, a Chinese children’s entertainment and media company, in its $134 million going private transaction.
• China Ming Yang Wind Power, a Chinese wind turbine maker (representation of Duff & Phelps, financial adviser to the special committee), in its $408 million going private transaction.
• Baidu in its $1.9 billion acquisition of 91 Wireless, a smartphone app distribution platform.
• Baidu in its $370 million acquisition of PPStream, a Chinese peer-to-peer streaming video network.
• Baidu in its spinoff of Youa.
• Beijing E-Town International Investment & Development and Chipone Technology in the $136 million acquisition of Integrated Memory Logic, a top provider of analog mixed-signal solutions for the flat panel display market.
• Keystone Lodging Holdings in its RMB8.3 billion sale of a controlling stake to Shanghai Jinjiang.
• AAC Technologies, a world-leading miniature technologies solution provider, in its acquisition of WiSpry, a US fabless semiconductor company.
• A top PE fund, as a consortium member, in connection with the privatization of 111, Inc. (Nasdaq: YI), a leading digital and mobile healthcare platform in China.
• IDG Ventures (as a consortium member) in the going private transaction of Soko Fitness & Spa Group.
• Loyal Valley Innovation Capital in its acquisition of Knowles’ mobile consumer electronics business.
• Riswein Health Industry Investment in its acquisition of 51% of GRS-HS, a subsidiary of Genesis HealthCare, a US NYSE-listed healthcare company.
• SIMIC Holdings, as a bidder for a manufacturer and supplier of precision-engineered products for transport and handling of semiconductors with market coverage of Asia and the US in an auction process.
• OraSure Technologies in its proposed acquisition of a rapid testing kit company.
• WinHealth Pharma in its bidding of a pharmaceutical company.

Private equity / venture capital investments

• HongShan in multiple equity investments in technology and life sciences companies.
• Tencent in multiple equity investments in technology companies.
• BlackRock in multiple equity investments in late-stage life sciences companies.
• Gaorong Ventures in multiple equity investments in technology companies.
• CBC Group in multiple equity investments in life sciences companies.
• Joy Capital in multiple equity investments in technology companies.
• Lightspeed China Partners in multiple equity investments in technology companies.
• Eight Roads in multiple equity investments in life sciences companies.
• Lilly Asia Ventures in multiple equity investments in life sciences companies.
• New Enterprise Associates in multiple equity investments in early-stage and late-stage technology and life sciences companies.
• Unicorn Capital Partners in multiple equity investments in technology and life sciences companies.
• Future Capital in multiple equity investments in technology companies.
• Advantech Capital in multiple equity investments in life sciences companies.
• Legend Biotech in multiple equity investments in life sciences companies.
• GGV Capital in its exit from from portfolio companies. 
• Xiang He Capital in multiple equity investments in technology companies.
• Alliance Ventures in multiple equity investments in technology companies.
• Baidu in multiple rounds of equity investments in iQIYI.
• Ascendent Capital Partners in its $500 million investment in WM Tech Corporation, the Cayman holding company of Wumei’s supermarket business.
• BPEA EQT in its equity investment in JD Industrial.
• Changchun High & New Technology in its equity investment in and exit from life sciences companies.
• E15 in multiple investments in life sciences companies.
• Sailing Capital as lead investor, in connection with the $77 million Series A financing of DMAI, a US cognitive artificial intelligence platform. 
• SJ Semiconductor Corp. in its $30 million Series A financing, $280 million Series B financing, $300 million Series C financing, $340 million Series C+ financing and $700 million new financing round.
• Burning Galaxy, a gaming company, in its multiple equity financings.
• Octillion Energy Holdings, a leading multi-national energy storage company that specializes in designing and manufacturing battery systems for major industries focused on electrified product lines, in its multiple equity financings.
• WinHealth Pharma, a company dedicated to providing innovative therapies for patients with rare diseases and other unmet medical needs, in its multiple equity financings.
  

• HongShan in its joint venture with Li Ning Company.
• Tencent in its joint venture with Roblox.
• Unity in its joint venture with investors, including Alibaba, China Mobile and OPPO.
• GitLab in connection with setting up an equity joint venture enterprise with Hongshan and Gaocheng Capital to enter the Chinese market and develop a localized version of its cutting-edge digital repository platform.
• Affinity Equity Partners in its joint venture with Beijing Sanyuan.
• Alien Technology, a US provider of radio-frequency identification (RFID) tags, chips and readers, in its joint venture with Shanghai Ruizhang Investment.
• Katerra in its joint venture with Shanghai Dangoo Electronics.
• Aclaris Therapeutics in its global license agreement with Biosion.
• WinHealth Pharma in its transfer of license.